General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Amgen Inc.(MODEST), NovoNordisk(SIGNIFICANT), Altimmune(MODEST), Merck(MODEST), MJH Life Sciences(MODEST) RESEARCH/RESEARCH GRANTS: Novartis(MODEST), Boehringer Ingelheim Pharmaceuticals, Inc(MODEST) OTHER FINANCIAL BENEFIT: Esperion(SIGNIFICANT)

View Full Disclosure